tradingkey.logo
tradingkey.logo

OptimizeRx Corp

OPRX
12.480USD
-0.280-2.19%
終値 12/26, 16:00ET15分遅れの株価
232.03M時価総額
2888.89直近12ヶ月PER

OptimizeRx Corp

12.480
-0.280-2.19%

詳細情報 OptimizeRx Corp 企業名

OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.

OptimizeRx Corpの企業情報

企業コードOPRX
会社名OptimizeRx Corp
上場日May 18, 2005
最高経営責任者「CEO」Silvestro (Stephen L)
従業員数106
証券種類Ordinary Share
決算期末May 18
本社所在地260 Charles Street
都市WALTHAM
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号02453
電話番号12486516558
ウェブサイトhttps://www.optimizerx.com/
企業コードOPRX
上場日May 18, 2005
最高経営責任者「CEO」Silvestro (Stephen L)

OptimizeRx Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
386.03K
+2.62%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
139.76K
+3.73%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
76.86K
-2.16%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
74.49K
+19.62%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
69.57K
+3.48%
Mr. Andy D'Silva
Mr. Andy D'Silva
Chief Business Officer
Chief Business Officer
46.31K
-2.54%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
43.90K
+29.00%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
30.93K
-26.45%
Ms. Catherine M. Klema
Ms. Catherine M. Klema
Independent Director
Independent Director
14.98K
+193.15%
Mr. Brendan Merrell
Mr. Brendan Merrell
Chief Operating Officer
Chief Operating Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
386.03K
+2.62%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
139.76K
+3.73%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
76.86K
-2.16%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
74.49K
+19.62%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
69.57K
+3.48%
Mr. Andy D'Silva
Mr. Andy D'Silva
Chief Business Officer
Chief Business Officer
46.31K
-2.54%

収益内訳

会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
Whetstone Capital Advisors, LLC
8.09%
Weintraub (Michael)
7.43%
The Vanguard Group, Inc.
5.68%
BlackRock Institutional Trust Company, N.A.
5.67%
Royce Investment Partners
3.63%
他の
69.49%
株主統計
株主統計
比率
Whetstone Capital Advisors, LLC
8.09%
Weintraub (Michael)
7.43%
The Vanguard Group, Inc.
5.68%
BlackRock Institutional Trust Company, N.A.
5.67%
Royce Investment Partners
3.63%
他の
69.49%
種類
株主統計
比率
Investment Advisor
34.87%
Investment Advisor/Hedge Fund
22.55%
Individual Investor
16.38%
Hedge Fund
12.09%
Research Firm
4.75%
Pension Fund
0.78%
Bank and Trust
0.14%
Insurance Company
0.04%
他の
8.40%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
268
13.52M
72.70%
-5.62M
2025Q2
261
14.95M
80.84%
-7.34M
2025Q1
267
15.34M
83.16%
-6.19M
2024Q4
295
14.49M
78.68%
-4.45M
2024Q3
303
15.96M
87.07%
-2.38M
2024Q2
340
16.48M
89.93%
-3.43M
2024Q1
347
15.94M
87.64%
-3.60M
2023Q4
378
15.63M
86.21%
-4.61M
2023Q3
399
14.49M
86.61%
-5.94M
2023Q2
406
14.23M
85.34%
-7.19M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Whetstone Capital Advisors, LLC
1.51M
8.12%
--
--
Jun 30, 2025
Weintraub (Michael)
1.38M
7.46%
--
--
Apr 29, 2025
The Vanguard Group, Inc.
920.88K
4.96%
-963.00
-0.10%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.09M
5.89%
-72.63K
-6.23%
Jun 30, 2025
Royce Investment Partners
790.64K
4.26%
-203.66K
-20.48%
Jun 30, 2025
Kennedy Capital Management LLC
472.47K
2.54%
-5.93K
-1.24%
Jun 30, 2025
William Blair & Company, L.L.C. (Research)
628.93K
3.39%
-2.10K
-0.33%
Jun 30, 2025
Rice Hall James & Associates, LLC
607.56K
3.27%
+31.39K
+5.45%
Jun 30, 2025
Febbo (William J)
530.85K
2.86%
-83.11K
-13.54%
Apr 29, 2025
Parkman Healthcare Partners LLC
507.42K
2.73%
+32.42K
+6.83%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
AAM Sawgrass US Small Cap Quality Growth ETF
1.37%
Janus Henderson Small Cap Growth Alpha ETF
0.57%
Invesco Dorsey Wright SmallCap Momentum ETF
0.57%
Even Herd Long Short ETF
0.19%
Vanguard US Multifactor ETF
0.1%
Vanguard US Momentum Factor ETF
0.1%
iShares Micro-Cap ETF
0.06%
Principal U.S. Small-Cap ETF
0.05%
Avantis US Small Cap Equity ETF
0.03%
iShares Russell 2000 Growth ETF
0.02%
詳細を見る
AAM Sawgrass US Small Cap Quality Growth ETF
比率1.37%
Janus Henderson Small Cap Growth Alpha ETF
比率0.57%
Invesco Dorsey Wright SmallCap Momentum ETF
比率0.57%
Even Herd Long Short ETF
比率0.19%
Vanguard US Multifactor ETF
比率0.1%
Vanguard US Momentum Factor ETF
比率0.1%
iShares Micro-Cap ETF
比率0.06%
Principal U.S. Small-Cap ETF
比率0.05%
Avantis US Small Cap Equity ETF
比率0.03%
iShares Russell 2000 Growth ETF
比率0.02%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

OptimizeRx Corpの上位5名の株主は誰ですか?

OptimizeRx Corpの上位5名の株主は以下のとおりです。
Whetstone Capital Advisors, LLCは1.51M株を保有しており、これは全体の8.12%に相当します。
Weintraub (Michael)は1.38M株を保有しており、これは全体の7.46%に相当します。
The Vanguard Group, Inc.は920.88K株を保有しており、これは全体の4.96%に相当します。
BlackRock Institutional Trust Company, N.A.は1.09M株を保有しており、これは全体の5.89%に相当します。
Royce Investment Partnersは790.64K株を保有しており、これは全体の4.26%に相当します。

OptimizeRx Corpの株主タイプ上位3種は何ですか?

OptimizeRx Corpの株主タイプ上位3種は、
Whetstone Capital Advisors, LLC
Weintraub (Michael)
The Vanguard Group, Inc.

OptimizeRx Corp(OPRX)の株式を保有している機関の数はいくつですか?

2025Q3時点で、OptimizeRx Corpの株式を保有している機関は268社あり、保有株式の総市場価値は約13.52Mで、全体の72.70%を占めています。2025Q2と比較して、機関の持ち株は-8.14%増加しています。

OptimizeRx Corpの最大の収益源は何ですか?

--において、--部門がOptimizeRx Corpにとって最大の収益を生み出しており、その金額は--で、全収益の--%を占めています。
KeyAI